274 related articles for article (PubMed ID: 10694923)
21. [Pathological aspects of water transport in the collecting ducts].
Bichet DG
Nephrologie; 1996; 17(7):417-22. PubMed ID: 9019668
[TBL] [Abstract][Full Text] [Related]
22. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
Schoneberg T; Yun J; Wenkert D; Wess J
EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
[TBL] [Abstract][Full Text] [Related]
23. Compound deletion of the rhoGAP C1 and V2 vasopressin receptor genes in a patient with nephrogenic diabetes insipidus.
Schöneberg T; Pasel K; von Baehr V; Schulz A; Volk HD; Gudermann T; Filler G
Hum Mutat; 1999; 14(2):163-74. PubMed ID: 10425039
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus.
van den Ouweland AM; Dreesen JC; Verdijk M; Knoers NV; Monnens LA; Rocchi M; van Oost BA
Nat Genet; 1992 Oct; 2(2):99-102. PubMed ID: 1303271
[TBL] [Abstract][Full Text] [Related]
25. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
[TBL] [Abstract][Full Text] [Related]
26. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
Faerch M; Christensen JH; Corydon TJ; Kamperis K; de Zegher F; Gregersen N; Robertson GL; Rittig S
Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
[TBL] [Abstract][Full Text] [Related]
27. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
Ishikawa SE
Nihon Rinsho; 2002 Feb; 60(2):350-5. PubMed ID: 11857925
[TBL] [Abstract][Full Text] [Related]
28. Molecular and cellular defects in nephrogenic diabetes insipidus.
Knoers NV; Deen PM
Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
[TBL] [Abstract][Full Text] [Related]
29. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
Los EL; Deen PM; Robben JH
J Neuroendocrinol; 2010 May; 22(5):393-9. PubMed ID: 20163515
[TBL] [Abstract][Full Text] [Related]
30. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
[TBL] [Abstract][Full Text] [Related]
31. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
Wildin RS; Cogdell DE; Valadez V
Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
[TBL] [Abstract][Full Text] [Related]
32. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.
Rosenthal SM; Feldman BJ; Vargas GA; Gitelman SE
Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():66-70. PubMed ID: 17261972
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
Böselt I; Tramma D; Kalamitsou S; Niemeyer T; Nykänen P; Gräf KJ; Krude H; Marenzi KS; Di Candia S; Schöneberg T; Schulz A
Nephrol Dial Transplant; 2012 Apr; 27(4):1521-8. PubMed ID: 21917732
[TBL] [Abstract][Full Text] [Related]
34. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
Schöneberg T; Schulz A; Biebermann H; Grüters A; Grimm T; Hübschmann K; Filler G; Gudermann T; Schultz G
Hum Mutat; 1998; 12(3):196-205. PubMed ID: 9711877
[TBL] [Abstract][Full Text] [Related]
35. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
[TBL] [Abstract][Full Text] [Related]
36. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
[TBL] [Abstract][Full Text] [Related]
38. [Nephrogenic diabetes insipidus].
Bichet DG
Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
[TBL] [Abstract][Full Text] [Related]
39. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.
Boson WL; Della Manna T; Damiani D; Miranda DM; Gadelha MR; Liberman B; Correa H; Romano-Silva MA; Friedman E; Silva FF; Ribeiro PA; De Marco L
Genet Test; 2006; 10(3):157-62. PubMed ID: 17020465
[TBL] [Abstract][Full Text] [Related]
40. Nephrogenic diabetes insipidus.
Morello JP; Bichet DG
Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
